Mitsutaka Osawa
Overview
Explore the profile of Mitsutaka Osawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Teraoka Y, Uchida T, Imamura M, Hiraga N, Osawa M, Kan H, et al.
J Gen Virol
. 2018 Jun;
99(8):1058-1065.
PMID: 29916799
Combined daclatasvir (DCV)/asunaprevir (ASV) plus beclabuvir (BCV) treatment shows a high virological response for genotype 1b chronic hepatitis C patients. However, its efficacy for patients for whom previous direct-acting antiviral...
12.
Teraoka Y, Uchida T, Imamura M, Osawa M, Tsuge M, Abe-Chayama H, et al.
Biochem Biophys Res Commun
. 2018 Apr;
500(2):152-157.
PMID: 29621544
Patients with chronic hepatitis C virus (HCV) infection who have failed to respond to direct-acting antiviral (DAA) treatment often acquire drug resistance-associated variants (RAVs). The NS5A-P32 deletion (P32del) RAV confers...
13.
Osawa M, Saitoh S, Fujiyama S, Kawamura Y, Sezaki H, Hosaka T, et al.
Intern Med
. 2017 Sep;
56(22):3033-3040.
PMID: 28943584
A 35-year-old male patient who showed sustained virological response (SVR) following treatment for hepatitis C virus infection developed liver cancer. The lesion was identified by imaging studies, with atypical findings...
14.
Osawa M, Akuta N, Suzuki F, Fujiyama S, Kawamura Y, Sezaki H, et al.
J Med Virol
. 2017 Jul;
89(12):2144-2148.
PMID: 28667756
With rapidly aging population in the world, many elderly patients present with hepatitis B virus (HBV) infection. We conducted a retrospective cohort study involving 359 untreated HBV patients aged 60...
15.
Teraoka Y, Kimura T, Aikata H, Daijo K, Osawa M, Honda F, et al.
Hepatol Res
. 2017 May;
48(2):193-204.
PMID: 28544062
Aim: To evaluate the safety and efficacy of stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma (HCC) in elderly patients. Methods: From 2008 to 2015, 117 patients with...